Biotin and Conjunctivitis exacerbated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis exacerbated is reported as a side effect among people who take Biotin (biotin), especially for people who are female, 50-59 old, also take Vitamin D3, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Conjunctivitis exacerbated when taking Biotin. It is created by eHealthMe based on reports of 33,728 people who have side effects when taking Biotin from the FDA, and is updated regularly.

What is Biotin?

Biotin has active ingredients of biotin. It is often used in hair loss. eHealthMe is studying from 35,393 Biotin users. Check the latest studies of Biotin.

What is Conjunctivitis exacerbated?

Conjunctivitis exacerbated (bad situation of conjunctivitis) is found to be associated with 1,067 drugs and 426 conditions by eHealthMe. Check the latest studies of Conjunctivitis exacerbated.

On Jul, 08, 2026

33,728 people reported to have side effects when taking Biotin.
Among them, 57 people (0.17%) have Conjunctivitis exacerbated.

Could Biotin cause Conjunctivitis exacerbated?

Among these 57 people:

What is the gender of people who have Conjunctivitis exacerbated when taking Biotin? *

female: 94.55 %
male: 5.45 %

What is the age of people who have Conjunctivitis exacerbated when taking Biotin? *

What are other drugs people take besides Biotin? *

What are other side effects people have besides Conjunctivitis exacerbated? *

Sinusitis (inflammation of sinus): 23 people, 40.35%
Nausea (feeling of having an urge to vomit): 13 people, 22.81%
Fatigue (feeling of tiredness): 12 people, 21.05%
Urinary Tract Infection: 12 people, 21.05%
Headache (pain in head): 10 people, 17.54%
Nasopharyngitis (inflammation of the nasopharynx): 10 people, 17.54%
Pain In Extremity: 10 people, 17.54%
Pneumonia: 10 people, 17.54%
Weakness: 9 people, 15.79%
Sinus Disorder (disease of sinus): 9 people, 15.79%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 19 people, 33.33%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 5 people, 8.77%
Urine Analysis Abnormal: 4 people, 7.02%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 7.02%
High Blood Pressure: 4 people, 7.02%
Muscle Aches (muscle pain): 4 people, 7.02%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 4 people, 7.02%
Hypocitraturia (low amount of citrate in the urine, is an important risk factor for kidney stone formation): 4 people, 7.02%
Lewis-Sumner Syndrome (a dysimmune multifocal demyelinating sensorimotor neuropathy): 4 people, 7.02%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Biotin and have Conjunctivitis exacerbated?

- Check whether Conjunctivitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Biotin:

Biotin (35,393 reports)

Browse all side effects of Biotin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (1,067 drugs)

Browse all the conditions that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (426 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on biotin (the active ingredients of Biotin) and Biotin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.